GlassScriptPhysician profile
Mobasser Mahmood
NPI 1912381997
$23,497.84
in general payments reported to CMS, 2019-2025
23 companies · $577 in 2025
The $577 reported for 2025 was more than what 76% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,263 · 2020: $396 · 2021: $5,888 · 2022: $11K · 2023: $2,417 · 2024: $2,154 · 2025: $577.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,776 · Food and Beverage: $2,372.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,776.02 |
| Food and Beverage | $2,371.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $19,797.91 | 2021-2025 | Evera Mri Xt Dr Surescan, Arctic Front Advance, Micra |
| Abbott Laboratories | $911.65 | 2021-2025 | Tacticath Ablation Catheter, Sensor Enabled, Xience Skypoint, Viewmate |
| Janssen Pharmaceuticals, INC | $632.44 | 2019-2021 | |
| Boston Scientific Corporation | $382.32 | 2021-2025 | Acuity Steerable, Farapulse, Lux-Dx Insertable Cardiac Monitor |
| Biosense Webster, INC. | $323.20 | 2022-2023 | Octaray Mapping Catheter, Carto 3 |
| Medtronic Vascular, INC. | $191.70 | 2019 | |
| Esperion Therapeutics, INC. | $178.16 | 2020-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $174.02 | 2019-2021 | |
| Amgen INC. | $171.72 | 2019-2022 | |
| Abiomed | $155.49 | 2019-2023 | Impella |
| Atricure, INC. | $124.63 | 2019 | |
| Novartis Pharmaceuticals Corporation | $119.33 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $69.84 | 2019-2021 | |
| Chiesi USA, INC. | $55.34 | 2019-2021 | |
| Edwards Lifesciences Corporation | $35.56 | 2023 | Hemosphere, Sapien 3 Ultra Resilia |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiva Medical, INC. | $35.06 | 2020-2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Shockwave Medical, INC | $34.12 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Pfizer INC. | $25.44 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.61 | 2020 | |
| Biotronik INC. | $20.09 | 2019 | |
| Amryt Pharma Holdings LTD | $14.47 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $12.87 | 2019 | |
| Cardiovascular Systems INC. | $10.87 | 2023 | Diamondback Coronary |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mobasser Mahmood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.